Literature DB >> 361199

Carcinoembryonic antigen (CEA) in clinical medicine: historical perspectives, pitfalls and projections.

P Gold, J Shuster, S O Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 361199     DOI： 10.1002/1097-0142(197809)42:3+<1399::aid-cncr2820420803>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  19 in total

1.  Detection of tumor-associated membrane proteins in prostate and bladder carcinomas by means of protein blotting.

Authors:  S A Ford; P J Russell; M Jelbart; D Raghavan
Journal:  Urol Res       Date:  1989

2.  Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.

Authors:  Raphael L C Araujo; Mithat Gönen; Peter Allen; Ronald DeMatteo; Peter Kingham; William Jarnagin; Michael D'Angelica; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2015-01-13       Impact factor: 5.344

3.  Detection of a soluble form of the leukocyte surface antigen CD48 in plasma and its elevation in patients with lymphoid leukemias and arthritis.

Authors:  G M Smith; J Biggs; B Norris; P Anderson-Stewart; R Ward
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

4.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion.

Authors:  Konstantinos Karatolios; Sabine Pankuweit; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 5.  History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.

Authors:  Haruhiko Nakamura; Toshihide Nishimura
Journal:  Surg Today       Date:  2017-02-22       Impact factor: 2.549

6.  Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.

Authors:  Sharmeela Kaushal; Michele K McElroy; George A Luiken; Mark A Talamini; A R Moossa; Robert M Hoffman; Michael Bouvet
Journal:  J Gastrointest Surg       Date:  2008-07-30       Impact factor: 3.452

7.  Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.

Authors:  Kosin Wirasorn; Thundon Ngamprasertchai; Jarin Chindaprasirt; Aumkhae Sookprasert; Narong Khantikaew; Ake Pakkhem; Piti Ungarereevittaya
Journal:  World J Gastrointest Oncol       Date:  2013-04-15

8.  Evaluation of CEA, CA 19-9, CA-50, CA-195, and TATI with special reference to pancreatic disorders.

Authors:  P Masson; B Pålsson; A Andren-Sandberg
Journal:  Int J Pancreatol       Date:  1991-05

9.  Immunohistochemical evidence for the expression of the carcinoembryonic antigen by human thymic epithelial cells in vitro and in neoplastic conditions.

Authors:  W Savino; D Durand; M Dardenne
Journal:  Am J Pathol       Date:  1985-12       Impact factor: 4.307

10.  Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients.

Authors:  R Molina; G Zanón; X Filella; F Moreno; J Jo; M Daniels; M L Latre; N Giménez; J Pahisa; M Velasco
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.